MusclePharm Ret. em ativos
Qual é o Ret. em ativos de MusclePharm?
O Ret. em ativos de MusclePharm Corp. é -66.50%
Qual é a definição de Ret. em ativos?
Retorno sobre os ativos indica como os ativos de uma empresa são lucrativos na geração de receita. É calculado dividindo-se o lucro líquido pelo total de ativos médios.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. em ativos de empresas na Setor Consumer Staples em OTC em comparação com MusclePharm
O que MusclePharm faz?
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Empresas com ret. em ativos semelhantes a MusclePharm
- 96763 tem Ret. em ativos de -66.68%
- G Medical Innovations Ltd tem Ret. em ativos de -66.65%
- Deinove SA tem Ret. em ativos de -66.64%
- Richland Resources International tem Ret. em ativos de -66.59%
- Nevtah Capital Management tem Ret. em ativos de -66.59%
- NanoViricides Inc tem Ret. em ativos de -66.51%
- MusclePharm tem Ret. em ativos de -66.50%
- Marker Therapeutics tem Ret. em ativos de -66.50%
- Ri Ying tem Ret. em ativos de -66.47%
- Valeritas tem Ret. em ativos de -66.46%
- Classic Minerals tem Ret. em ativos de -66.40%
- NTN Buzztime Inc tem Ret. em ativos de -66.38%
- Nuheara tem Ret. em ativos de -66.30%